Ngokusho kwe-Oral Cancer Foundation, umuntu ufa kusukela emdlalweni womlomo njalo njalo ihora e-United States yedwa. Lo mdlavuza, otholakala emlonyeni, izindebe noma umphimbo, uvame ukuphulukiswa kakhulu uma utholakala futhi uphathwa ngokushesha. Ngeshwa, ezinyathelweni zakuqala, umdlavuza womlomo ungabonakali.
Labo abasengozini enkulu yomdlavuza womlomo bahlanganisa abasebenzisi begwayi , amadoda ase-Afrika-America, nabaphuza kakhulu, kodwa noma ubani angahlakulela umdlavuza ngomlomo.
Ngokusho kwe-Oral Cancer Consortium, amaphesenti angu-25 abantu abathola ukuthi unomdlavuza womlomo awunazo izinto eziyingozi. Ucwaningo luye lwazimisela ukuthi kungaba khona ukuxhumana phakathi kwe- HPV (igciwane lomuntu we-papilloma) nomdlavuza womlomo.
Mayelana ne-Canal Cancers
Umdlavuza womlomo ngokuvamile uvela lapho amangqamuzana emilonyeni yakho noma emlonyeni wakho enza izinguquko (izinguquko) ku-DNA yazo. Lezi zinguquko zivumela ukuthi amangqamuzana omdlavuza aqhubeke ekhula futhi ehlukana lapho amaseli aphilile efa. Amangqamuzana omdlavuza womlomo angakha isisu esingase sibonakale ezingxenyeni ezihlukahlukene zomlomo wakho njengalokhu ohlangothini noma ngaphansi kolimi lwakho. Ngokuhamba kwesikhathi bangase basakaze kwezinye izindawo zomlomo nakwezinye izindawo zekhanda nentamo noma ezinye izingxenye zomzimba.
Amakhansela omlomo ngokuvamile avame ukuqala amangqamuzana amancane, amancane (amangqamuzana angama-squamous) abeka izindebe zakho ngaphakathi nangomlomo wakho. Iningi lamangqamuzana omlomo angama-squamous cell carcinomas.
Akucaci ukuthi yini ebangelwa ukuguqulwa kwamangqamuzana angqamuzana aholela emdlalweni wesibeletho.
Kodwa odokotela baye baveza izici ezingase zande ingozi yomdlavuza womlomo.
Ukuhlolwa kwe-Canal Oral
Udokotela wamazinyo wakho kanye nomuthi wezokuhlanza ngokuvamile bakuhlolisisa nganoma yiziphi izimpawu zomdlavuza womlomo lapho uhlolisiswa njalo, kodwa ezinye izimpawu zomdlavuza womlomo zingabonakali emehlweni.
I-FDA ivumele idivayisi ukuthi ithole umdlavuza womlomo obizwa nge-VELscope.
I-VELscope ayiyona ingavamile futhi isebenzisa ukukhanya okukhanyayo okwesibhakabhaka ukugcizelela noma yikuphi ushintsho emlonyeni odokotela bamazinyo noma abahlanzekile abangenakukwazi ukubona.
Ukuhlolwa komdlavuza womlomo ngodokotela wakho wamazinyo kuyashesha, kungenabuhlungu futhi kuyadingeka ukuze uyibambe ezinyathelweni zayo zakuqala. I-American Dental Association ichaza ukuthi phakathi nokuhlola kwakho kwamazinyo okuvamile, udokotela wamazinyo wakho uhlola ngeso lengqondo izindebe nobuso bakho ukuze uthole izimpawu zokusakaza ngaphezu komlomo wakho. Ekutshaleni umdlavuza womlomo angase abuyele entanyeni nasendlini yomhlathi, futhi ahlolisise kokubili ulimi oluphezulu nangaphansi. Lezi zibuko zomdlavuza zomlomo kufanele zenziwe eceleni kwesilingo sakho samazinyo njalo ezinyangeni eziyisithupha noma uma uthola noma yiziphi izimpawu zokuxwayisa.
UDkt. Kenneth Magid, uprofesa eNew York University College of Dentistry, uthi kwi-website ye-Oral Cancer Foundation, "Inkinga, ikakhulukazi, leyo mdlavuza wokuqala ngomlomo ibonakala njengento yonke. sishintsha emathinini emlonyeni. Indawo ebomvu noma indawo emhlophe. Siyabona ngaso sonke isikhathi. " Kodwa ukusebenzisa i-VELscope ukuthola umdlavuza womlomo kungenza ukungajwayelekile kubonakale njengezithupha ezinkulu, ngokusho kukaDkt. Magid.
I-Oral Cancer Foundation inquma ukuthi abantu abangu-34 000 baseMelika bayotholakala benomdlavuza womlomo kulo nyaka kuphela, kanti amaphesenti angu-50 kuphela asaphila eminyakeni emihlanu.
Inkinga inkulu kakhulu emhlabeni wonke. Ngisho nalezi zibalo, ochwepheshe bayavuma ukuthi ukuxilongwa okusheshayo kuqhuma izinga leminyaka emihlanu lokusinda kumaphesenti angu-80 emangalisayo.
Njengoba umdlavuza womlomo ungathinta noma ubani, ngaphandle kobudala noma ubulili, kubalulekile ukuthi ube nokuhlolwa okuvamile kwalesi sifo esibulalayo. Khuluma nodokotela wamazinyo mayelana nentuthuko yakamuva kanye nobuchwepheshe bokuthola umdlavuza womlomo.
Imithombo:
> I-Oral Cancer Foundation. "Ukutholakala Ngaphambi Kokuqala Kuyisihluthulelo Sokushaya I-Canal Oral." 18 Julayi 2007.